Skip to main content
Clinical Trials/JPRN-jRCTs051220167
JPRN-jRCTs051220167
Recruiting
Phase 2

A randomized trial to evaluate the nutritional support with ISOCAL CLEAR and rehabilitation on prevention of skeletal muscle mass loss -a pilot study

Kiyoshi Maeda0 sites40 target enrollmentFebruary 13, 2023

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Esophageal Cancer
Sponsor
Kiyoshi Maeda
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 13, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kiyoshi Maeda

Eligibility Criteria

Inclusion Criteria

  • (1\)Histologically proven squamous cell carcinoma, adenosquamous carcinoma, or basaloid cell carcinoma.
  • (2\)Stage II\-III
  • (3\)Aged 20 years and older.
  • (4\)ECOG Performance status 0 or 1\.
  • (5\)oral intake is possible
  • (6\)Major organ function is preserved.
  • (7\)Witten informed consent is obtained.

Exclusion Criteria

  • (1\)Simultaneous or metachronous (within 5 years) double cancers , with the exception of intramucosal tumor curable with local therapy.
  • (2\)Active infection requiring systemic therapy.
  • (3\)Fever over 38 degrees Celsius
  • (4\)Female during pregnancy, within 28 days of postparturition, or during lactation. Male who wants partner's pregnancy.
  • (5\)Psychological disorder difficult to participate in this clinical study.
  • (6\)Diabetes mellitus uncontrollable with continuous use of insuline or hypoglycemic agents.
  • (7\)Severe emphysema, interstitial pneumonia or pulmonary fibrosis based on chest CT.
  • (8\)Uncontrolled arterial hypertension.
  • (9\)Drug history of opioids, or stroids.
  • (10\)History of unstable angina pectoris within three weeks or myocardial infarction within six months before registration.

Outcomes

Primary Outcomes

Not specified

Similar Trials